AngioDynamics Reports Fiscal 2023 Third Quarter Financial Results; Revises Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/25/2026
- S&P 500, Nasdaq end down on tech stocks, investors weigh Iran moves
- Oil drops more than $2 despite new US sanctions on Iran
- UBS says bull market has further to run
- S&P 500 may pull back before midterms, but Citi says buy the dip
- Global yield relief evaporates as U.S. rates push back toward multi-decade peaks
- Wattmore and Eos Energy strike non-exclusive storage software deal
- Grand Canyon Education places CFO on leave amid stock trade probe
- S&P 500, Nasdaq end down on tech stocks, investors weigh Iran moves
- Funds sell $44bn in semiconductors on AI concerns
- RUM Group signs $13.7 billion GPU services deal, issues warrants
AngioDynamics (ANGO) Misses Q3 EPS by 2c, Offers Guidance
March 30, 2023 7:05 AM EDTAngioDynamics (NASDAQ: ANGO) reported Q3 EPS of ($0.03), $0.02 worse than the analyst estimate of ($0.01). Revenue for the quarter came in at $80.7 million versus the consensus estimate of $83.2 million.
GUIDANCE:
AngioDynamics sees FY2023 EPS of ($0.06)-($0.01), versus the consensus of ($0.01). AngioDynamics sees... More
